tradingkey.logo

DaVita Inc

DVA
查看详细走势图
140.830USD
-8.390-5.62%
收盘 02/06, 16:00美东报价延迟15分钟
9.65B总市值
14.00市盈率 TTM

DaVita Inc

140.830
-8.390-5.62%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-5.62%

5天

+28.80%

1月

+22.76%

6月

+10.19%

今年开始到现在

+23.96%

1年

-18.16%

查看详细走势图

TradingKey DaVita Inc股票评分

单位: USD 更新时间: 2026-02-06

操作建议

DaVita Inc当前公司基本面数据相对稳定,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗服务供应商行业排名27/75位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价150.51。中期看,股价处于上升通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

DaVita Inc评分

相关信息

行业排名
27 / 75
全市场排名
147 / 4521
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

DaVita Inc亮点

亮点风险
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
估值合理
公司最新PE估值14.00,处于3年历史合理位
机构加仓
最新机构持股36.29M股,环比增加0.04%
加拿大丰业银行分红基金持仓
明星投资者加拿大丰业银行分红基金持仓,最新持仓市值4.93K

分析师目标

根据 10 位分析师
持有
评级
150.514
目标均价
+0.87%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

DaVita Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

DaVita Inc简介

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
公司代码DVA
公司DaVita Inc
CEORodriguez (Javier J)
网址https://www.davita.com/
KeyAI